802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

Summary

The primary objective of the study is to evaluate the efficacy of BIIB074 in treating pain experienced by participants with trigeminal neuralgia (TN). Secondary objectives of this study are to investigate the safety and tolerability of BIIB074 in participants with TN and to evaluate the population pharmacokinetics (PK) of BIIB074.

Timeline

Start

2023-04-19

Primary completion

2025-10-14

Completion

2026-08-21

Drugs

Indications